Literature DB >> 20508483

Rhizopus oryzae skin infection treated with posaconazole in a boy with chronic granulomatous disease.

Joanne G Wildenbeest, Matthijs W Oomen, Roger J Brüggemann, Martin de Boer, Yuma Bijleveld, J Merlijn van den Berg, Taco W Kuijpers, Dasja Pajkrt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20508483     DOI： 10.1097/INF.0b013e3181dc8352

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  4 in total

1.  Therapeutic drug monitoring of posaconazole oral suspension in paediatric patients younger than 13 years of age: a retrospective analysis and literature review.

Authors:  T Jancel; P A Shaw; C W Hallahan; T Kim; A F Freeman; S M Holland; S R Penzak
Journal:  J Clin Pharm Ther       Date:  2016-12-16       Impact factor: 2.512

Review 2.  Primary Cutaneous Mucormycosis Caused by Rhizopus oryzae: A Case Report and Review of Literature.

Authors:  Erika Rodríguez-Lobato; Lourdes Ramírez-Hobak; Jorge E Aquino-Matus; Juan P Ramírez-Hinojosa; Víctor H Lozano-Fernández; Juan Xicohtencatl-Cortes; Rigoberto Hernández-Castro; Roberto Arenas
Journal:  Mycopathologia       Date:  2016-11-03       Impact factor: 2.574

3.  Sporothrix schenckii lymphadentitis in a male with X-linked chronic granulomatous disease.

Authors:  Jessica R Trotter; Panida Sriaroon; David Berman; Aleksandra Petrovic; Jennifer W Leiding
Journal:  J Clin Immunol       Date:  2013-11-16       Impact factor: 8.317

4.  Invasive mucormycosis in chronic granulomatous disease.

Authors:  Abdulnasir M Al-Otaibi; Dayel A Al-Shahrani; Eman M Al-Idrissi; Hail M Al-Abdely
Journal:  Saudi Med J       Date:  2016-05       Impact factor: 1.484
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.